Assessing the Quality of Life Using the Health Utilities Index Questionnaire in Children With Severe Persistent Asthma During the Treatment With Omalizumab
Background. Quality of life (QoL) is an important parameter that provides additional information about changes in health status. Objective. Our aim was to study the change in QoL of patients with severe persistent bronchial asthma (BA) during the treatment with genetically engineered biological prep...
Saved in:
Main Authors: | Leyla S. Namazova-Baranova (Author), Elena A. Vishnеva (Author), Elena A. Dobrynina (Author), Irina V. Vinyarskaya (Author), Anna A. Alekseeva (Author), Vladislav V. Chernikov (Author), Lilia R. Selimsianova (Author) |
---|---|
Format: | Book |
Published: |
Union of pediatricians of Russia,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry
by: Elena A. Vishneva, et al.
Published: (2018) -
A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab - Actual Russian Clinical Practice Data
by: A. S. Kolbin, et al.
Published: (2016) -
PRIMARY RESULTS OF LONG-TERM DYNAMIC MONITORING OF CHILDREN WITH BRONCHIAL ASTHMA OF UNCONTROLLED SEVERE PERSISTENT COURSE
by: L. S. Namazova-Baranova, et al.
Published: (2017) -
Efficiency of Adding Omalizumab to Standard Therapy for Children with Recurrent Spontaneous Urticaria: Comparative Observational Study
by: Vera G. Kalugina, et al.
Published: (2020) -
Results of Therapy Including Omalizumab in Adolescents With Recurrent Urticaria: Retrospective Cohort Study
by: Vera G. Kalugina, et al.
Published: (2019)